ARISING HEALTHALIVE. AWAKE. AWARE.Follow The Arising ↗

← October 11, 2026 edition

THE ARISING · Longevity & Healthspan

A Year of Remote Exercise Slowed Biological Aging in Breast Cancer Survivors

Breast cancer survivors who followed a year-long exercise program delivered remotely showed slower biological aging in their blood than survivors in a comparison wellness program, according to a new randomized trial analysis.

Conceptual artwork accompanying The Arising.

The work appeared in the Journal of the National Cancer Institute in 2026. It is a secondary analysis of a randomized controlled trial, which is the strongest design for testing whether an intervention works. The analysis covered 124 participants who had complete data. Because it looks at a subset of a larger trial, it is best read as a promising signal, not a final answer.

Cancer and its treatments are linked to faster biological aging and to problems with thinking among survivors, the authors write. Biological aging here means a measure taken from the blood, not a birthday count. Researchers read chemical tags on DNA, called methylation, and feed them into formulas known as epigenetic clocks. These clocks estimate how old the body appears to be. Higher readings have been tied to greater risk of illness and early death.

The participants were breast cancer survivors who were sedentary and within five years of diagnosis. They were randomly assigned to one of two groups. One group received an exercise program delivered remotely. The other received a health and wellness program matched for the amount of contact. That matching helps ensure that any difference is not simply due to getting more attention.

Blood samples and thinking tests were collected at the start, at 6 months and at 12 months.

Over the 12 months, the exercise group showed slower epigenetic aging than the wellness group on two clocks. On the GrimAge2 clock the difference was statistically significant at P = .02. On the DNAmFitAge clock it was significant at P = .002. GrimAge2 was built to predict mortality and illness risk, according to the paper that introduced it, which tested it in 13,399 blood samples across nine cohorts of mostly older adults.

The study also linked clock changes to changes in thinking. Survivors whose epigenetic aging sped up more tended to show greater decline in attention and in self-reported cognition. That means how well people felt they were thinking, as they described it themselves. This is an association. It does not show that faster aging caused the decline, or the reverse.

The researchers also scanned the blood epigenome and found sites where methylation differed between the groups. Some of those sites sit in genes tied to BDNF signaling. BDNF is brain-derived neurotrophic factor, a protein involved in brain cell health.

The authors conclude that a 12-month exercise program was associated with slower epigenetic aging. They suggest biological aging may be one way exercise supports cognitive health after cancer. That is their interpretation, and the study design does not prove it.

Some limits matter for readers. The sample is modest. The blood clocks are estimates, and they are not the same as measured health outcomes such as disease or survival.

A commenter on the Fight Aging! site raised a similar point. The commenter noted that DNAmFitAge is trained on measures of physical fitness, so an exercise group moving on it is less surprising. The commenter called GrimAge2 the more meaningful result and said the P value of .02 in a small subsample is fragile. These are the commenter's views, not findings from the study. The commenter also said they are an AI agent.

The same page also described cancer survivors as carrying more senescent cells, which are aging cells that stop dividing, and suggested exercise may help by supporting cellular cleanup. That is the coverage's context.

For cancer survivors, the practical message is cautious but encouraging. A program delivered remotely was linked to a healthier blood aging profile over a year.

What to watch next

The full paper's numbers on the size of the clock difference, and larger trials that test whether these blood changes translate into better thinking and health outcomes.

  1. First Human Data on Cell-Rejuvenating Gene Therapy Show It Was Well Tolerated, With Early Vision Gains in Glaucoma 2. Gut Bacteria Compound ImP Linked to Higher Alzheimer's Risk and Faster Cognitive Decline 3. Menopause Leaves a Blood Protein Signature Linked to Brain Aging and Dementia Risk 4. Hidden Artery Plaque Found in More Than Half of Healthy Adults, Including 1 in 13 Under 30 5. Ultra-Processed Meals Linked to Higher Insulin, and Food Images to Different Brain Reward Responses, Even When Nutrients Match 6. Foundation Reports First Human Doses of Partial Epigenetic Reprogramming Gene Therapy, Given Outside Formal Trials 7. A Year of Remote Exercise Slowed Biological Aging in Breast Cancer Survivors 8. Semaglutide Extends Lifespan in Older Mice, Outperforming Calorie Restriction on Some Measures

THE ARISING NEWSLETTER

Science moves forward.
Come with it.

Research, clear explanations, and a little room for wonder.
Read and follow The Arising on Substack.

Find The Arising on Substack ↗